Singh, A., & Chen, H. (2020). Optimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)–Positive Non–Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors. Cancer Manag Res.
Chicago Style CitationSingh, Abhay, and Hongbin Chen. "Optimal Care for Patients With Anaplastic Lymphoma Kinase (ALK)–Positive Non–Small Cell Lung Cancer: A Review On the Role and Utility of ALK Inhibitors." Cancer Manag Res 2020.
MLA CitationSingh, Abhay, and Hongbin Chen. "Optimal Care for Patients With Anaplastic Lymphoma Kinase (ALK)–Positive Non–Small Cell Lung Cancer: A Review On the Role and Utility of ALK Inhibitors." Cancer Manag Res 2020.
Warning: These citations may not always be 100% accurate.